Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenytoin for Corticosteroid-induced Cognitive Changes
NCT00591006Phase 3Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jan 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of phenytoin in corticosteroid-induced cognitive impairment, sponsored by UT Southwestern Medical Center. Primary endpoint: Rey Auditory Verbal Learning Test Total T-Score. Started Jan 2008; status: completed.
02
Drugs
phenytoin
03
Conditions
corticosteroid-induced cognitive impairment
Beyond the preview
Go deeper on NCT00591006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00591006.